GuerraFScappiniLMaoloAet al. CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care2016.
2.
FreedmanBPotparaTSLipGYH. Stroke prevention in atrial fibrillation. Lancet2016; 388: 806–817.
3.
WatsonTShantsilaELipGY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet2009; 373: 155–166.
4.
LipGYHSkjothFNielsenPBet al. Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy. Thromb Haemost2015; 114: 826–834.
5.
ShantsilaELipGY. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. Cochrane Database Syst Rev2016; 9: CD003333.
6.
LaneDALipGYH. Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation2012; 126: 860–865.
7.
LowresNNeubeckLRedfernJet al. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost2013; 110: 213–222.
8.
MartinezCKatholingAFreedmanSB. Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. Thromb Haemost2014; 112: 276–286.
9.
MazurekMJędrzejczyk-PatejELenarczykRet al. Do we need to monitor the percentage of biventricular pacing day by day?Int J Cardiol2016; 221: 81–89.
10.
GlotzerT VHellkampASZimmermanJet al.; MOST investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation2003; 107: 1614–1619.
11.
TayalAHTianMKellyKMet al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology2008; 71: 1696–1701.
12.
MegaJLBraunwaldEWiviottSDet al.; ATLAS ACS 2–TIMI 51 investigators. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med2012; 366: 9–19.
13.
LahayeSRegpalaSLacombeSet al. Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation. Thromb Haemost2013; 111: 456–473.
14.
LaneDALipGYH. Patient’s values and preferences for stroke prevention in atrial fibrillation: Balancing stroke and bleeding risk with oral anticoagulation. Thromb Haemost2014; 111: 381–383.
